NYC Legionnaires' Outbreak 2026
About Legionnaires' Disease
What is Legionnaires' disease?
Legionnaires' disease is a serious type of pneumonia (lung infection) caused by Legionella bacteria. The bacteria live naturally in fresh water but become a problem when they grow in building water systems — especially the cooling towers used in large air-conditioning systems, but also hot tubs, decorative fountains, and plumbing. It is named after a 1976 outbreak at an American Legion convention in Philadelphia.
How does it spread?
You cannot catch Legionnaires' from another person. People get sick by breathing in tiny droplets of water (mist or vapor) that contain the bacteria — for example, mist drifting from a contaminated rooftop cooling tower. This is why outbreaks cluster around a specific building or neighborhood rather than spreading city-wide, and why the fix is cleaning the water source rather than isolating patients.
What are the symptoms?
Symptoms usually begin 2 to 10 days after exposure and look like a bad pneumonia: cough, fever, shortness of breath, muscle aches, and headache. Some people also have diarrhea, nausea, or confusion. Because it resembles other kinds of pneumonia, it can be missed unless doctors know to test for Legionella — which matters during an outbreak.
Who is most at risk?
Most healthy people exposed to the bacteria do not get sick. The disease is most dangerous for adults over 50, current or former smokers, and people with chronic lung disease or weakened immune systems. In this group it can be severe or fatal, which is why prompt antibiotic treatment matters.
Sources: CDC About Legionnaires' · WHO Legionellosis · NYC Health
Treatments & Vaccines in Development
Legionnaires' disease is very treatable with common antibiotics when caught early. There is no vaccine — because the bacteria live in building water systems rather than spreading between people, prevention is about cleaning cooling towers, not immunization.
Legionnaires' disease is treated with antibiotics, and fluoroquinolones like levofloxacin are a first-line choice because they penetrate lung tissue well and have shown high cure rates. Started promptly, they are very effective. Delay is the main danger, so anyone with pneumonia symptoms linked to an outbreak area should be treated quickly.
CDC / clinical literature →A macrolide antibiotic used as an alternative first-line treatment for Legionnaires' disease. Both fluoroquinolones and macrolides are effective; the choice depends on the patient. Most people recover with prompt antibiotic treatment, though the disease can be severe or fatal in older adults and those with weak lungs or immune systems.
CDC →There is no vaccine for Legionnaires' disease, and preventive antibiotics do not work. Because the bacteria live in building water systems rather than spreading between people, prevention focuses on maintaining and disinfecting cooling towers, plumbing, and hot tubs — not immunization. No vaccine candidate is in advanced development.
WHO Legionellosis →